Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! Download free report on life science investment in China.

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Ascentage's IND Accepted in US for Inhibitor of Apoptosis Blocker
RiboQuark Doses First Patient in China siRNA Trial
Eye Tech Care's Ultrasound Glaucoma Treatment Approved for China Use
MabSpace Biosciences Files China IND for Second-Gen PD-L1
BeyondSpring Starts Phase II/III China Trial of Neutropenia Drug
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China